FAK goes nuclear to control antitumor immunity-a new target in cancer immuno-therapy

Alan Serrels1, Margaret C Frame1

  • 1Cancer Research UK Edinburgh Center, Institute of Genetics and Molecular Medicine, University of Edinburgh , Edinburgh, UK.

Oncoimmunology
|May 4, 2016
PubMed

Insights

Cancer cells evade immune attack by controlling regulatory T cells (Tregs). Nuclear Focal Adhesion Kinase (FAK) regulates Treg levels, suggesting FAK inhibitors could promote immune-mediated tumor regression.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor immune evasion is crucial for cancer progression.
  • Regulatory T cells (Tregs) play a significant role in suppressing antitumor immune responses.
  • Focal Adhesion Kinase (FAK) is a key signaling protein involved in cell functions.

Purpose of the Study:

  • To investigate the role of nuclear Focal Adhesion Kinase (FAK) activity in regulating tumor-infiltrating regulatory T cells (Tregs).
  • To explore the potential of targeting nuclear FAK activity for cancer immunotherapy.

Main Methods:

  • Analysis of nuclear FAK activity in cancer cells.
  • Assessment of Treg levels within tumors.
  • Evaluation of chemokine and cytokine gene expression in cancer cells.
  • Investigating the effects of FAK inhibitors on tumor immune microenvironment and regression.

Main Results:

  • Nuclear FAK activity was found to unexpectedly control tumor Treg levels.
  • FAK regulates the transcription of chemokines and cytokines in cancer cells, influencing immune evasion.
  • Targeting nuclear FAK activity impacts the tumor immune microenvironment.

Conclusions:

  • Nuclear FAK activity is a novel regulator of immune evasion in cancer by modulating Treg populations.
  • FAK kinase inhibitors represent a potential therapeutic strategy to overcome immune suppression and induce tumor regression.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K